INDIANAPOLIS, Aug. 14, 2017 -- Event fundraisers from JDRF and Human Rights Campaign, along with other fundraising experts and thought leaders, will present fundraising best practices and trends at RAISE 2017, the first national conference for event fundraising professionals, September 25-26 in Washington, DC. Click to Tweet.
RAISE 2017, sponsored by BidPal®, is a one-day conference and will be preceded by a half-day user conference and cocktail networking reception. The conference will enable fundraising professionals to share and discover relevant trends, engage with industry peers, and learn from industry insiders. In addition to Lynn Page, national director of signature events at JDRF and Mike Wilkinson, deputy director of events for Human Rights Campaign, featured speakers include Sophie Streeter, director of special events for Loyola Academy in Chicago; Nhu Te, editor of NonProfit Pro; author, speaker and coach Mike Merriam; and Ben Farrell from Custom Benefit Auctions.
Topics will include data driven fundraising, storytelling using humor and emotion to electrify donors, running efficient and profitable campaigns, building cohesive procurement teams, registration/checkout best practices and a full panel discussion on event fundraising trends.
“The event fundraising field is constantly evolving. Donor demographics are changing and fundraisers need to think about new and innovative ways to engage and retain donors,” said BidPal CEO Steve Johns. “RAISE 2017 will provide event fundraisers a dynamic way to discover new ideas and learn new skills that will help benefit their causes, while providing an opportunity to learn from and network with peers.”
Participants at RAISE 2017 have the ability to earn up to four Certified Fund Raising Executive (CFRE) continuing education credits.
RAISE 2017 will be held at The Event Space at YFU in downtown Washington, DC. Early registration is available for $99 before September 1; regular registration is $149. Registration is online at http://raise.bidpal.com/.
About BidPal, Inc.
BidPal creates user-friendly fundraising software that helps nonprofits engage donors, raise more money and save valuable time and resources. Our cloud-based mobile and payment solutions have helped thousands of organizations raise more than $1 billion through 10,000 events and connect with over one million unique donors. Located in the marketing technology hub of Indianapolis, BidPal has been recognized on the Inc. 500 list of Fastest Growing Companies and has received a Techpoint MIRA award for Mobile Technology Excellence & Innovation. Connect with us on Facebook at Twitter.
For information, contact: Linda Muskin, 847.432.7300 [email protected] Mara Conklin, 847.816.9411 [email protected]


Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 



